BIOGEN publishes study results for high-dose nusinersen in Nature Medicine
Go back to BIOGEN publishes study results for high-dose nusinersen in Nature Medicine| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 250.39 -3.45 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.84 | 52 Week High | $333.65 | |||
| Open | $251.68 | 52 Week Low | $223.02 | |||
| Day High | $252.27 | P/E | 32.06 | |||
| Day Low | $246.15 | EPS | $7.81 | |||
| Volume | 519,661 | |||||
| (NASDAQ: IONS) | Delayed: 42.88 -1.03 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.91 | 52 Week High | $62.68 | |||
| Open | $43.80 | 52 Week Low | $19.59 | |||
| Day High | $43.80 | P/E | N/A | |||
| Day Low | $42.58 | EPS | $0.00 | |||
| Volume | 1,353,318 | |||||



